Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
- PMID: 29389364
- PMCID: PMC5780297
- DOI: 10.1016/j.jacc.2017.11.037
Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
Figures

Similar articles
-
Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis.Hellenic J Cardiol. 2022 Mar-Apr;64:67-76. doi: 10.1016/j.hjc.2021.11.001. Epub 2021 Nov 29. Hellenic J Cardiol. 2022. PMID: 34856378
-
Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.Eur Heart J. 2020 Aug 1;41(29):2759-2767. doi: 10.1093/eurheartj/ehaa170. Eur Heart J. 2020. PMID: 32267922 Free PMC article.
-
Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement.ESC Heart Fail. 2024 Jun;11(3):1636-1646. doi: 10.1002/ehf2.14709. Epub 2024 Feb 26. ESC Heart Fail. 2024. PMID: 38407567 Free PMC article.
-
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis.ESC Heart Fail. 2022 Oct;9(5):3188-3197. doi: 10.1002/ehf2.13876. Epub 2022 Jun 29. ESC Heart Fail. 2022. PMID: 35770333 Free PMC article.
-
Aortic valve replacement in patients with amyloidosis.J Thorac Cardiovasc Surg. 2018 Jul;156(1):98-103. doi: 10.1016/j.jtcvs.2017.12.048. Epub 2017 Dec 19. J Thorac Cardiovasc Surg. 2018. PMID: 29397971
Cited by
-
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells.Nat Commun. 2021 May 25;12(1):3142. doi: 10.1038/s41467-021-23274-x. Nat Commun. 2021. PMID: 34035264 Free PMC article.
-
Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red Flags.J Clin Med. 2024 Jan 24;13(3):671. doi: 10.3390/jcm13030671. J Clin Med. 2024. PMID: 38337363 Free PMC article.
-
Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis.Nat Commun. 2021 Dec 7;12(1):7112. doi: 10.1038/s41467-021-27416-z. Nat Commun. 2021. PMID: 34876572 Free PMC article.
-
Re-Definition of the Epidemiology of Cardiac Amyloidosis.Biomedicines. 2022 Jun 30;10(7):1566. doi: 10.3390/biomedicines10071566. Biomedicines. 2022. PMID: 35884871 Free PMC article. Review.
-
Prognostic Value of Apical Sparing of Longitudinal Strain in Patients with Symptomatic Aortic Stenosis.Acta Cardiol Sin. 2022 May;38(3):341-351. doi: 10.6515/ACS.202205_38(3).20211209A. Acta Cardiol Sin. 2022. PMID: 35673342 Free PMC article.
References
-
- Gillmore J.D., Maurer M.S., Falk R.H. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–2412. - PubMed
-
- Tanskanen M., Peuralinna T., Polvikoski T. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232–239. - PubMed
-
- Treibel T.A., Fontana M., Gilbertson J.A. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. 2016;9 - PubMed
-
- González-López E., Gallego-Delgado M., Guzzo-Merello G. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36:2585–2594. - PubMed